Douglas L. Noordsy, MD

Can antipsychotics impact substance use or vocational  outcomes in patients with schizophrenia? Dr Douglas L. Noordsy, Associate  Professor of Psychiatry and Director of Psychosis Services at Geisel School of  Medicine at Dartmouth, New  Hampshire, will be answering that question and more during his presentation  with the same title at the 2012 

US  Psychiatric and Mental Health Congress

Here, Dr. Noordsy shares some highlights of the  presentation and sheds some light on the pharmacological and nonpharmacological  strategies to treat and manage comorbid schizophrenia and addiction as well as  strategies to help improve functional outcomes.

Podcasts

Pharmacological and nonpharmacological strategies to treat and manage comorbid schizophrenia and addiction concern psychiatrists who are learning strategies to help improve functional outcomes.

Douglas L. Noordsy, MD

Articles

Comorbid Schizophrenia and Substance Use-Moving Toward Improved Functional Outcomes